Clinical Oncology Next Generation Sequencing Market Size, Share, Growth, Trends and Forecast 2023
This report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
(EMAILWIRE.COM, October 18, 2018 ) In this report, Publisher studies the present scenario (with the base year being 2017) and the growth prospects of global Clinical Oncology Next Generation Sequencing (NGS) market for 2018-2023.
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
Over the next five years, Publisher projects that Clinical Oncology Next Generation Sequencing (NGS) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Clinical Oncology Next Generation Sequencing (NGS) market by product type, application, key companies and key regions.
Get Sample Copy of This Report: https://www.reportsweb.com/inquiry&RW00012275769/sample
The key players covered in this report:
Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen, Life Technologies, DNASTAR, Exosome Diagnostics, Biomatters, CLC Bio, BGI, Qiagen, Perkin Elmer, Pacific Bioscience, Partek, GnuBIO, Foundation Medicine, Paradigm, Caris Life Sciences, Myriad Genetics
To calculate the market size, Publisher considers value generated from the sales of the following segments:
Segmentation by product type:
NGS Pre-Sequencing
Sequencing
Primary, Secondary & Tertiary Data Analysis
Segmentation by application:
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Clinical Oncology Next Generation Sequencing (NGS) market size by key regions/countries, product type and application, history data from 2013 to 2018, and forecast to 2023.
To understand the structure of Clinical Oncology Next Generation Sequencing (NGS) market by identifying its various subsegments.
Focuses on the key global Clinical Oncology Next Generation Sequencing (NGS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Oncology Next Generation Sequencing (NGS) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Clinical Oncology Next Generation Sequencing (NGS) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Get More Information of this Report: https://www.reportsweb.com/inquiry&RW00012275769/buying
Table of Content
1 Industry Overview
1.1 Clinical Oncology Next Generation Sequencing Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Clinical Oncology Next Generation Sequencing Market by Type
2.1 By Type
2.1.1 UPS Type
2.1.2 Generators Type
2.1.3 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Industrial Application
3.1.2 Data Centre & Telecommunication
3.1.3 Government and Defense
3.1.4 Commercial Construction Building
3.1.5 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
6 Conclusion
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
Over the next five years, Publisher projects that Clinical Oncology Next Generation Sequencing (NGS) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Clinical Oncology Next Generation Sequencing (NGS) market by product type, application, key companies and key regions.
Get Sample Copy of This Report: https://www.reportsweb.com/inquiry&RW00012275769/sample
The key players covered in this report:
Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen, Life Technologies, DNASTAR, Exosome Diagnostics, Biomatters, CLC Bio, BGI, Qiagen, Perkin Elmer, Pacific Bioscience, Partek, GnuBIO, Foundation Medicine, Paradigm, Caris Life Sciences, Myriad Genetics
To calculate the market size, Publisher considers value generated from the sales of the following segments:
Segmentation by product type:
NGS Pre-Sequencing
Sequencing
Primary, Secondary & Tertiary Data Analysis
Segmentation by application:
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Clinical Oncology Next Generation Sequencing (NGS) market size by key regions/countries, product type and application, history data from 2013 to 2018, and forecast to 2023.
To understand the structure of Clinical Oncology Next Generation Sequencing (NGS) market by identifying its various subsegments.
Focuses on the key global Clinical Oncology Next Generation Sequencing (NGS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Oncology Next Generation Sequencing (NGS) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Clinical Oncology Next Generation Sequencing (NGS) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Get More Information of this Report: https://www.reportsweb.com/inquiry&RW00012275769/buying
Table of Content
1 Industry Overview
1.1 Clinical Oncology Next Generation Sequencing Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Clinical Oncology Next Generation Sequencing Market by Type
2.1 By Type
2.1.1 UPS Type
2.1.2 Generators Type
2.1.3 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Industrial Application
3.1.2 Data Centre & Telecommunication
3.1.3 Government and Defense
3.1.4 Commercial Construction Building
3.1.5 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
6 Conclusion
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results